Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Stuart Scott 30 for 30 showcases ESPN legend who changed the game
Stuart Scott is the subject of ESPN’s latest 30 for 30 film: “Boo-Yah: A Portrait of Stuart Scott,” which premieres on Dec. 10 at 9...
Mon Dec 8, 2025

Giving tours of Carolina strengthened Gillian Kepley’s love for it
If there was a record book for most campus tours given by a Carolina student, Gillian Kepley ’25 would probably find her name at the...
Sat Dec 6, 2025

UNC Alum, NASA Astronaut Zena Cardman Captures Incredible Visual Of Aurora From Space
UNC alumna Zena Cardman serves as the commander of NASA's SpaceX Crew-11 mission, which was launched on August 1, 2025. At the International Space Station,...
Fri Dec 5, 2025

What does it take to open a restaurant on Franklin Street?
Kenan-Flagler Business School professor Dr. Ted Zoller said restaurant culture in Chapel Hill manifests in the East Franklin Street and West Franklin Street markets, which...
Wed Dec 3, 2025